Effectiveness of Systemic Treatments for Pyoderma Gangrenosum:A Systematic Review of Observational Studies & Clinical Trials.
CONCLUSIONS: Systemic corticosteroids, cyclosporine, infliximab, and canakinumab had the most evidence in treating PG. However, current literature is limited to small and lower-quality studies with substantial heterogeneity. This article is protected by copyright. All rights reserved.
PMID: 29478243 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Partridge ACR, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P Tags: Br J Dermatol Source Type: research
More News: Aczone Gel | Clinical Trials | Corticosteroid Therapy | Dermatology | Prednisolone | Remicade | Restasis | Science | Skin | Study | UK Health